Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (151-160 of 420) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|September 1, 1980
Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disksR N Jones, A L Barry, C Thornsberry
Journal of Clinical Microbiology|October 1, 1982
Comparison of six different criteria for judging the acceptability of sputum specimensL K Wong, A L Barry, S M Horgan
Antimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D Brown
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methodsP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycinA L Barry, P C Fuchs, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1996
In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methodsA L Barry, S D Brown, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1995
Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disksA L Barry, S D Brown, W J Novick
The Journal of Antimicrobial Chemotherapy|April 1, 1993
The antibacterial activity of co-amoxiclavA L Barry, M A Pfaller, P C Fuchs
Antimicrobial Agents and Chemotherapy|October 1, 1996
In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agentsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1978
Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative studyA L Barry, R N Jones, T L Gavan
Pageof 42

Showing results (151-160 of 420) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|September 1, 1980
Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disksR N Jones, A L Barry, C Thornsberry
Journal of Clinical Microbiology|October 1, 1982
Comparison of six different criteria for judging the acceptability of sputum specimensL K Wong, A L Barry, S M Horgan
Antimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D Brown
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methodsP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycinA L Barry, P C Fuchs, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1996
In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methodsA L Barry, S D Brown, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1995
Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disksA L Barry, S D Brown, W J Novick
The Journal of Antimicrobial Chemotherapy|April 1, 1993
The antibacterial activity of co-amoxiclavA L Barry, M A Pfaller, P C Fuchs
Antimicrobial Agents and Chemotherapy|October 1, 1996
In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agentsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1978
Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative studyA L Barry, R N Jones, T L Gavan
Pageof 42